BFRI (Biofrontera) Days Payable : 65.45 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biofrontera Days Payable?

Biofrontera's average Accounts Payable for the three months ended in Dec. 2024 was $3.78 Mil. Biofrontera's Cost of Goods Sold for the three months ended in Dec. 2024 was $5.27 Mil. Hence, Biofrontera's Days Payable for the three months ended in Dec. 2024 was 65.45.

The historical rank and industry rank for Biofrontera's Days Payable or its related term are showing as below:

BFRI' s Days Payable Range Over the Past 10 Years
Min: 23.27 Med: 33.97 Max: 113.49
Current: 113.49

During the past 6 years, Biofrontera's highest Days Payable was 113.49. The lowest was 23.27. And the median was 33.97.

BFRI's Days Payable is ranked better than
65.01% of 946 companies
in the Drug Manufacturers industry
Industry Median: 85.82 vs BFRI: 113.49

Biofrontera's Days Payable declined from Dec. 2023 (101.40) to Dec. 2024 (65.45). It may suggest that Biofrontera accelerated paying its suppliers.

Biofrontera Days Payable Historical Data

The historical data trend for Biofrontera's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera Days Payable Chart

Biofrontera Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

51.03

33.97

23.27

47.98

50.65

Biofrontera Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															101.40	111.61	120.20	97.15	65.45

Competitive Comparison of Biofrontera's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofrontera's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera's Days Payable distribution charts can be found below:

* The bar in red indicates where Biofrontera's Days Payable falls into.

Biofrontera Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biofrontera's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (3.308	+	1.856)	/	2 )	/	18.607	*	365
=	2.582					/	18.607	*	365
=	50.65

Biofrontera's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (5.707	+	1.856)	/	2 )	/	5.272	*	365 / 4
=	3.7815					/	5.272	*	365 / 4
=	65.45

Biofrontera Days Payable Related Terms

Thank you for viewing the detailed overview of Biofrontera's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera Inc (NAS:BFRI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Presidential Way, Suite 330, Woburn, MA, USA, 01801

Website

https://www.biofrontera-us.com

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

Executives

Heikki Lanckriet	director	C/O BIOFRONTERA INC., 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Eugene Frederick Leffler	officer: Chief Financial Officer	84 BAY DRIVE, SUDBURY MA 01776
Kevin Daniel Weber	director	119 BUCHANAN COURT, CELINA TX 75009
Borer John J Iii	director	1270 AVENUE OF THE AMERICAS, 16TH FLOOR, NEW YORK NY 10020
Beth J. Hoffman	director	5895 BLAZING STAR LANE, SAN DIEGO CA 92130
Loretta M. Wedge	director	21260 WACISSA DRIVE, VENICE FL 34293
Ag Biofrontera	10 percent owner	HEMMELRATHER WEG 201, LEVERKUSEN 2M D-51377
Erica F. Gates	officer: Controller	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Erica L. Monaco	director, officer: Chief Financial Officer/COO	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Hermann Luebbert	director, officer: Chief Executive Officer	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801